Published in Curr Pharm Des on January 01, 2009
A case for pharmacogenomics in management of cardiac arrhythmias. Indian Pacing Electrophysiol J (2012) 0.75
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther (2008) 11.67
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med (1989) 9.08
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med (2005) 8.77
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation (2005) 8.76
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med (2008) 7.13
KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet (2006) 6.39
C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation (2001) 5.49
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol (2006) 5.39
Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med (1984) 5.02
Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med (2004) 4.99
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 4.85
Identification of a genetic locus for familial atrial fibrillation. N Engl J Med (1997) 4.66
Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science (2002) 4.40
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation (2007) 4.37
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation (2007) 4.10
Clinical practice. Long-QT syndrome. N Engl J Med (2008) 4.05
Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol (1997) 4.00
Predicting sudden death in the population: the Paris Prospective Study I. Circulation (1999) 3.80
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res (2005) 3.75
Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol (2008) 3.75
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet (2006) 3.15
Low penetrance in the long-QT syndrome: clinical impact. Circulation (1999) 3.14
Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol (2003) 3.09
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA (1993) 3.01
Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res (2007) 3.00
Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation (2007) 2.82
Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet (2004) 2.66
Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation (2006) 2.63
Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation (2006) 2.57
Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation (2008) 2.56
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation (2009) 2.55
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest (2008) 2.54
Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation (2007) 2.50
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation (2003) 2.42
Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation (2002) 2.30
Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation (2003) 2.28
Family history as a risk factor for primary cardiac arrest. Circulation (1998) 2.25
Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res (2001) 2.25
A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther (2007) 2.17
Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med (2008) 2.14
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J (2009) 2.06
The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation (2003) 2.03
A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation (2006) 1.98
Genetics of acquired long QT syndrome. J Clin Invest (2005) 1.96
Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome. Heart Rhythm (2008) 1.87
A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest (2006) 1.79
Prolonged signal-averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation. J Am Coll Cardiol (2008) 1.77
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation (2000) 1.72
Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell (2008) 1.70
Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation (1999) 1.69
Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol (2007) 1.67
CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart. Proc Natl Acad Sci U S A (2008) 1.66
KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med (2007) 1.56
Pharmacogenomics--ready for prime time? N Engl J Med (2008) 1.43
Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J (2002) 1.43
Brugada syndrome and sudden cardiac death in children. Lancet (2000) 1.40
Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol (2008) 1.33
Overview of the randomized trials to prevent stroke in atrial fibrillation. Ann Epidemiol (1993) 1.28
Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy. Circulation (2004) 1.21
SNP S1103Y in the cardiac sodium channel gene SCN5A is associated with cardiac arrhythmias and sudden death in a white family. J Med Genet (2002) 1.13
The Brugada syndrome. J Am Coll Cardiol (2008) 1.07
Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol (1991) 1.07
Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation (2001) 1.01
Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J Am Coll Cardiol (2003) 0.98
Postoperative atrial fibrillation: a billion-dollar problem. J Am Coll Cardiol (2004) 0.96
Risk factor interactions and genetic effects associated with post-operative atrial fibrillation. Pac Symp Biocomput (2006) 0.96
Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm (2004) 0.93
Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm (2006) 0.92
Single-nucleotide polymorphisms in SCN5A gene in Chinese Han population and their correlation with cardiac arrhythmias. Genet Med (2004) 0.86
A genotype-dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation genotype ECG-phenotype correlation in atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 0.84
Genetics of sudden cardiac arrest. Prog Cardiovasc Dis (2008) 0.83
Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J (2007) 0.80
Age-dependent association between hepatic lipase gene C-480T polymorphism and the risk of pre-hospital sudden cardiac death: the Helsinki Sudden Death Study. Atherosclerosis (2006) 0.80
Fetal presentation of congenital long QT syndrome. Pediatr Cardiol (1999) 0.80
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet (2009) 4.11
Clinical practice. Long-QT syndrome. N Engl J Med (2008) 4.05
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet (2011) 3.94
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Atrial Fibrillation Is an Independent Predictor of Mortality in Critically Ill Patients. Crit Care Med (2015) 2.77
Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation (2008) 2.72
Drug-induced long QT syndrome. Pharmacol Rev (2010) 2.55
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 2.23
Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med (2008) 2.14
Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. Mayo Clin Proc (2004) 2.11
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J (2009) 2.06
Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. J Am Coll Cardiol (2012) 1.84
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation. Heart Rhythm (2010) 1.77
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet (2009) 1.59
Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family. Heart Rhythm (2006) 1.57
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 1.56
ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling. Heart Rhythm (2009) 1.55
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 1.45
Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm (2009) 1.33
Identifying UMLS concepts from ECG Impressions using KnowledgeMap. AMIA Annu Symp Proc (2005) 1.32
Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation. J Mol Cell Cardiol (2009) 1.31
Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. J Am Coll Cardiol (2012) 1.27
A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation. Ann Emerg Med (2010) 1.15
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation (2014) 1.11
Race-specific impact of atrial fibrillation risk factors in blacks and whites in the southern community cohort study. Am J Cardiol (2012) 1.10
Pharmacogenomics: the genetics of variable drug responses. Circulation (2011) 1.10
A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation. J Am Coll Cardiol (2012) 1.06
Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion. Heart Rhythm (2013) 1.04
Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol (2012) 1.01
Atrial fibrillation and flutter outcomes and risk determination (AFFORD): design and rationale. J Cardiol (2011) 0.98
A KCNJ8 mutation associated with early repolarization and atrial fibrillation. Europace (2012) 0.97
Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies. Front Pharmacol (2012) 0.94
Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm. Dis Model Mech (2012) 0.93
Characterization of genome-wide association-identified variants for atrial fibrillation in African Americans. PLoS One (2012) 0.92
Differential impact of race and risk factors on incidence of atrial fibrillation. Am Heart J (2011) 0.91
Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation. Europace (2013) 0.89
Suppression of spontaneous ca elevations prevents atrial fibrillation in calsequestrin 2-null hearts. Circ Arrhythm Electrophysiol (2014) 0.88
The "missing" link in atrial fibrillation heritability. J Electrocardiol (2011) 0.87
Risk factors for bradycardia requiring pacemaker implantation in patients with atrial fibrillation. Am J Cardiol (2012) 0.86
On the relationship among QT interval, atrial fibrillation, and torsade de pointes. Europace (2007) 0.86
A genotype-dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation genotype ECG-phenotype correlation in atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 0.84
Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. Am J Cardiol (2012) 0.82
Selective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillation. Circ Arrhythm Electrophysiol (2013) 0.80
Lone AF - etiologic factors and genetic insights into pathophysiolgy. J Atr Fibrillation (2010) 0.80
Is it time to develop a "pathogenicity" score to distinguish long QT syndrome causing mutations from "background" genetic noise? Heart Rhythm (2009) 0.80
Evaluating the HATCH score for predicting progression to sustained atrial fibrillation in ED patients with new atrial fibrillation. Am J Emerg Med (2013) 0.80
Clinical use of and future perspectives on antiarrhythmic drugs. Eur J Clin Pharmacol (2008) 0.80
Screening for genomic alterations in congenital long QT syndrome. Heart Rhythm (2006) 0.79
Sotalol-induced torsades de pointes precipitated during treatment with oseltamivir for H1N1 influenza. Heart Rhythm (2010) 0.78
Genome-wide assessment for genetic variants associated with ventricular dysfunction after primary coronary artery bypass graft surgery. PLoS One (2011) 0.77
Repolarization recipes for atrial fibrillation: beyond single channel variants. J Am Coll Cardiol (2012) 0.77
Assessment of the Framingham risk factors among ED patients with newly diagnosed atrial fibrillation. Am J Emerg Med (2011) 0.75
Triggers for cardiac events in patients with type 2 long QT syndrome. Heart Rhythm (2010) 0.75
Cardiac sodium channel variants: action players with many faces. Heart Rhythm (2008) 0.75
Prevalence and predictors of atrial fibrillation among patients undergoing bariatric surgery. Obes Surg (2014) 0.75
Novel ECG markers for ventricular repolarization: Is the QT interval obsolete? Heart Rhythm (2011) 0.75
Implantable cardioverter-defibrillator malfunction due to mechanical failure of the header connection. J Cardiovasc Electrophysiol (2004) 0.75
Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet (2017) 0.75
A shock in time. Clin J Sport Med (2007) 0.75